Client: Confidential Global Biopharmaceutical Leader

Industry: Pharmaceuticals & Life Sciences

Project: Digital Opinion Leader Monitoring at a U.S.-Based Lung Cancer Conference

Therapeutic Areas: Small Cell Lung Cancer, Sickle Cell Disease, Rare Lung Conditions, Immunotherapy

Summary

RILA Global Consulting partnered with a leading global biopharmaceutical company to deliver real-time digital opinion leader (DOL) and key opinion leader (KOL) insights during a major U.S. lung cancer congress. Using social listening across platforms like X (Twitter), LinkedIn, Facebook, and Instagram, RILA monitored over 100 healthcare professionals and stakeholders to analyze perceptions around therapies, unmet needs, and clinical innovations in areas like small cell lung cancer and immunotherapy. Their strategy involved live monitoring, sentiment analysis, influencer profiling, and competitive benchmarking to identify top oncology voices and inform both local and global strategies. The results provided actionable intelligence for medical affairs and commercial teams, helping refine future engagement plans and optimize field activities. RILA, a leader in pharma-focused digital analytics, emphasized secure, ethical data practices and high-impact insights across the product lifecycle.

Event Intelligence at Scale: A Deep Dive into an Influential U.S. Oncology Congress

RILA GLOBAL CONSULTING partnered with a top-tier pharmaceutical company to provide high-impact social listening coverage and KOL analysis during a major U.S.-based cancer congress. This annual scientific meeting is one of the most prominent in thoracic oncology, featuring leading researchers, oncologists, and patient advocates.

Spanning multiple digital platforms—including X (formerly Twitter), LinkedIn, Facebook, and Instagram—our work focused on monitoring conversations from over 100+ healthcare professionals, researchers, and patient voices. The goal was to understand how thought leaders shape perceptions around emerging therapies, unmet needs, and clinical innovations across complex disease spaces.

Strategic Objectives

• Identify influential voices shaping online congress conversations in thoracic oncology

• Assess the impact of branded vs. unbranded narratives and engagement trends

• Deliver geographically segmented insights to inform local and global strategy

• Generate real-time, actionable intelligence to support both Medical Affairs and Commercial Teams

Tactical Execution

Our approach combined technology and expert human analysis:

• Real-Time Multi-Channel Monitoring during the event

• Custom Boolean Strings to track specific topics like immunotherapy resistance, treatment sequencing, and patient-reported outcomes

• Deep Profiling of KOLs and DOLs using publication data, clinical trial involvement, conference participation, and social reach

• Narrative Clustering and Sentiment Analysis to surface core themes and stakeholder reactions

• Competitor Benchmarking on influencer mentions and message penetration

Impact Delivered

• Identified top 50+ oncology influencers including thoracic surgeons, medical oncologists, advocacy leaders, and academic researchers

• Mapped the digital ecosystem around SCLC and biomarker-driven therapies

• Equipped client teams with shareable insights and visual dashboards used internally for field planning, MSL briefings, and strategic reporting

• Informed future engagement strategies through trend analysis on advocacy, unmet needs, and therapy adoption

About RILA GLOBAL CONSULTING

RILA GLOBAL CONSULTING is a premier agency specializing in digital consumer and behavior analytics, with a strong focus on the pharmaceutical and healthcare sectors. Our award-winning firm delivers social listening and market intelligence solutions that power brand strategies, medical affairs insights, and clinical trial innovation.

Our work is grounded in HIPAA and GDPR compliance, ensuring secure and ethical handling of sensitive healthcare data. We understand the pharmacovigilance process through our work with global pharma clients and offer PV alerting capabilities for Adverse Events (AEs), Product Quality Complaints (PQCs), and Product Misuse Reports (MDCs).

We have led projects in rare diseases, sickle cell anemia, small cell lung cancer, multiple sclerosis, and inflammatory conditions, collaborating directly with Medical Affairs, Commercial, Patient Advocacy, and Innovation teams to create impact across the lifecycle of a product.

RILA combines cultural intelligence, AI-powered insights, and multilingual capabilities to deliver high-precision research that meets global standards and drives real-world results.

Ready to Transform How You Listen?

Whether your brand is entering a new therapeutic area or preparing for your next congress, our KOL & DOL intelligence will give your team a strategic edge.

👉 Contact us at hello@rilaglobal.com